essensys Returns to Profitability Amid Strategic Restructuring and Possible Founder Takeover Offer

FY25 results: revenue down 21% but EBITDA back in the black

essensys has delivered a cleaner, leaner set of full year numbers for the twelve months to 31 July 2025. Revenue fell to £19.2m, down 21% year on year, largely due to the previously flagged downsizing of a single large strategic customer and a deliberate move away from lower quality non-recurring sales. Despite that, Adjusted EBITDA swung to a £1.3m profit from a £0.9m loss.

Adjusted EBITDA is a profitability measure that strips out non-cash and one-off items to show core trading. It matters here because management’s cost actions and product mix shift have improved underlying margins even as top line shrank. Statutory loss before tax widened slightly to £5.7m and loss per share was (8.6)p.

What changed under the bonnet: mix, margins and cost discipline

Recurring revenue held up better than the headline, at £16.9m (down 17%), and now makes up 88% of total revenue. Gross margin improved to 59% from 57%, helped by a higher software mix and a more focused operating model.

Operating expenses were cut by 32% to £10.0m, reflecting the data centre shutdowns and tighter cost control. The completed data centre decommissioning programme delivered £1.5m of annualised savings, with two final closures planned in FY26 as the business shifts to a pure-play SaaS model.

ARR and churn: understanding the 26% drop

Run Rate ARR fell to £15.0m, down 26%. ARR is the annualised value of monthly recurring revenue at a point in time, a key forward-looking indicator for subscription businesses. The drop was principally the single large customer downsizing. Excluding that customer and at constant currency (restating for FX to aid comparability), Run Rate ARR decreased by 5%.

For strategic customers specifically, ARR decreased by 2% at constant currency, with a shift away from lower margin Cloud and into essensys Platform, which now represents 72% of ARR. One strategic customer did not renew a £0.9m ARR Platform contract at the end of December 2025, which was already included in management forecasts.

Regional picture

• North America revenue: £10.5m (down 26%). Excluding the large customer and at constant currency, North America Run Rate ARR decreased by 1% and remains 51% of total ARR.
• UK & Europe revenue: £7.2m (down 16%). Net sites up by 7 versus FY24 year end, though ARR declined by 15% due to non-strategic losses and reduced demand for Operate.
• APAC revenue: £1.5m (up 6%). 15 new sites added, a 58% increase.

Product strategy: elumo launch and the pivot to platform

elumo, the bookings and access solution for meeting rooms and shared spaces, launched in H2 FY25 and has landed initial sales across the UK, US and Australia, including a 20-site portfolio with an existing US customer. Management says sales cycles are elongated in the current environment, but they expect strong medium-term demand.

To accelerate adoption and retention, the business has been restructured around two cores: a dedicated, agile team to drive elumo new business, and a focused essensys Platform team to deepen relationships, improve service and actively manage churn. This should align go-to-market with product maturity and support scalability.

Cash, balance sheet and a potential debt facility

Year-end cash was £1.8m, down from £3.1m. The Group is debt free and in discussions to secure a debt facility to optimise its capital structure and support growth. Management notes cash outflows reduced in H2 and that additional cost savings from the restructure, alongside the completed data centre programme, should protect cash generation.

The Board has modelled a range of scenarios and is confident that, even under a significant long-term downturn, the Group will have sufficient cash resources for the foreseeable future. Still, with cash modest and ARR lower, the proposed debt facility looks important for headroom.

FY26 outlook: materially below expectations as sales cycles lengthen

Q1 FY26 revenue came in at £4.1m, broadly in line with expectations and primarily from essensys Platform. However, management now expects FY26 performance to be materially below their expectations due to the volatile macro environment and slower than anticipated elumo adoption.

Key watch-outs for investors this year: pace of elumo wins and deployments, net churn on Platform, strategic customer stability, and progress securing a debt facility. Management continues to lean into operational resilience, disciplined cash management and targeted go-to-market.

Possible founder offer at 20p: what investors should know

As flagged on 28 November 2025, founder and Non-Executive Director Mark Furness has submitted a preliminary, indicative, non-binding proposal to acquire the entire issued and to be issued share capital at 20 pence per share, via a to-be-incorporated company.

The Independent Directors are in early-stage discussions. There is no certainty an offer will be made. If it proceeds, it could provide a valuation reference point in the near term. Equally, there is no deal certainty and no timetable disclosed.

My take: higher-quality model emerging, but near-term growth is the rub

Positives first. The shift to a software-first mix, higher gross margins, and the return to Adjusted EBITDA profitability show the model can generate cash when right-sized. The data centre closures and restructure simplify operations, and elumo gives essensys a second scalable entry point to land and expand with customers.

On the flip side, ARR down 26% is chunky, cash is light at £1.8m, and FY26 is guided as materially below expectations. Sales cycles are longer and one strategic customer did not renew £0.9m ARR. The proposed debt facility is sensible, in my view, to buttress the balance sheet while elumo ramps.

If elumo starts to deliver portfolio deals at pace and churn on Platform remains well-managed, earnings quality should continue to improve. The possible 20p offer adds an interesting wrinkle, but it is early days and not guaranteed. For now, this is a story of operational progress and margin quality versus slower growth and macro drag.

Key figures from essensys FY25

Revenue	£19.2m (FY24: £24.1m)
Recurring revenue	£16.9m (down 17%)
Run Rate ARR (July 2025)	£15.0m (down 26%)
Gross margin	59% (FY24: 57%)
Adjusted EBITDA	£1.3m (FY24: £0.9m loss)
Statutory loss before tax	£(5.7)m
Loss per share	(8.6)p
Cash at year end	£1.8m; debt free
Q1 FY26 revenue	£4.1m
Annualised cost savings from data centre closures	£1.5m
Possible all-cash offer	20 pence per share; preliminary and non-binding

Jargon buster

• Adjusted EBITDA: earnings before interest, tax, depreciation and amortisation, excluding exceptional and non-trading items like restructuring and share-based payments.
• ARR: Run Rate Annual Recurring Revenue, the annualised value of monthly recurring revenue at a point in time.
• Constant currency: restating results using prior period exchange rates to remove FX effects.
• SaaS: software-as-a-service, typically subscription software delivered via the cloud.
• Churn: customers or revenue that do not renew or are lost.